Physician
Premier Pediatrics PLLC
Premier Pediatrics PLLC was paid $2.02M by Medicaid between Jul 2019 and Dec 2024, across 29 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoPREMIER PEDIATRICS PLLC
FORT SMITH, AR 72916
FORT SMITH, AR 72916
33aNPI1588121065assigned 02/21/2019
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$2.02M
24GClaims46,508
24DCodes billed29
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Arkansas
Rank by total paid#2 of 9
Median peer was paid$1.13M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 5,745 | $202K | |
| 2020 | 7,580 | $321K | |
| 2021 | 9,973 | $454K | |
| 2022 | 9,309 | $455K | |
| 2023 | 6,471 | $267K | |
| 2024incomplete | 7,430 | $322K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 10,944 | 10,357 | $597K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 11,127 | 10,523 | $315K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 14% | 2,612 | 2,440 | $278K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.8% | 2,093 | 1,945 | $199K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 9.5% | 4,330 | 4,021 | $191K |
| 87634 | 5.0% | 1,287 | 1,221 | $102K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.7% | 2,009 | 1,766 | $95K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.9% | 1,145 | 1,021 | $58K |
| 71046 | Radiologic examination, chest; 2 views | 2.7% | 1,953 | 1,802 | $55K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.8% | 676 | 616 | $36K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 569 | 530 | $30K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.2% | 488 | 475 | $24K |
17 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 305 | $12K |
| 74018 | <1% | 253 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 78 | $6K |
| 99382 | <1% | 77 | $2K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 19 | $2K |
| 99051 | <1% | 5,357 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 29 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 114 | $1K |
| 99381 | <1% | 30 | $1K | |
| 81007 | <1% | 334 | $1K | |
| 99383 | <1% | 47 | $902.56 | |
| 87807 | <1% | 74 | $820.21 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | $667.03 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 26 | $288.63 |
| 81003 | <1% | 121 | $238.68 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 366 | $151.01 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 29 | $140.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPOLLARD, STACI (OFFICE MANAGER)